Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Bold Brews Beat Weight-Loss Drugs: Nestle CEO's Confident Declaration

Weight-loss drugs no match for Nestle's coffee empire, claims CEO. Discover how Nestle plans to keep their caffeine-filled kingdom thriving!

Top News

Argenx Crashes 25% As The Setbacks Mount For Its Hallmark Drug, Vyvgart

Argenx stock crashed early Wednesday after its treatment for an autoimmune disease that causes skin blisters flopped in a Phase 3 study.

Investors Business Daily

Analyzing 3 Pharma Stocks for Year-End Gains?

The pharma industry is well-positioned for expansion owing to growing healthcare spending and the adoption of cutting-edge technologies to develop new drugs. Amid this backdrop, let’s analyze the investment prospects of fundamentally strong pharma stocks Eli Lilly (LLY), Teva Pharmaceutical (TEVA), and Johnson & Johnson (JNJ) for year-end gains. Read…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Analyzing Buy or Hold Options for 3 Medical Stocks

The medical industry is thriving due to rising demand for healthcare products and services, fueling significant returns. Given the solid long-term prospects of the industry, let’s analyze fundamentally sound medical stocks McKesson (MCK), Zimmer Biomet (ZBH) and Fresenius SE (FSNUY).

StockNews.com

Pfizer Sues Poland And Hungary Over Covid Debts

Pharmaceutical firms Pfizer and BioNTech are suing the governments of Poland and Hungary alleging they failed to pay for vaccines ordered during the Covid pandemic, lawyers said Tuesday.

International Business Times

The good news for women: a drug to limit hot flushes. The bad: it could cost you £430 a month

Veoza reduces the severity of this common menopausal symptom. But at £430 a month, only the wealthy will gain just now, says Guardian columnist Devi Sridhar

The Guardian - UK

Are These 3 Pharma Stocks Smart Buys for Bullish Investors?

The pharmaceutical industry's outlook looks promising, given robust healthcare spending worldwide and the rapid adoption of advanced digital technologies. Amid this, let’s find out if pharma stocks AbbVie (ABBV), Collegium Pharmaceutical (COLL), and Merck (MRK) are ideal buys now. Read on to know more….

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

How the Michelle Mone scandal unfolded: £200m of PPE contracts, denials and a government lawsuit

Conservative peer made multiple denials of any association between her and PPE Medpro

The Guardian - UK

Supreme Court to Review Nationwide Restrictions on Abortion Pill

US Supreme Court to decide on restricting abortion drug Mifepristone. Attorney General Bob Ferguson discusses potential ramifications and possible tactics.

Top News

Stakeholders express dismay as Centre readies to regulate medical devices alongside drugs

Concerned groups express dismay over proposed New Drugs, Cosmetics and Medical Device Bill, 2023, citing inadequate addressing of key issues and lack of external input.

The Hindu

FDA Spots Control Irregularities in Moderna's US Plant

Dive into the intriguing saga of unanticipated control failures at Moderna's magnate production plant, a juicy scoop exclusively unraveled by the meticulou...

Top News

The Pain Continues For Bedraggled Pharma Heavyweight Pfizer

Another analyst cut estimates on Pfizer stock on Friday after the pharma heavyweight earlier this week issued a disappointing 2024 guide.

Investors Business Daily

Older Americans to pay less for some drug treatments as drugmakers penalized for big price jumps

Hundreds of thousands of older Americans could pay less for outpatient drug treatments beginning early next year

The Independent UK

Moderna Stock Soars On 'Transformational' Potential Of Its Merck-Tied Cancer Vaccine

Moderna's Merck-partnered cancer vaccine reduced the risk of relapse or death by 49% in melanoma patients. Moderna stock soared.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Vivek Ramaswamy spins conspiracy theories at bad-tempered CNN town hall

Republican presidential candidate sparred with host Abby Phillip at Iowa event

International Business Times

Pfizer Shares Tumble On Disappointing 2024 Profit Outlook

Pfizer issued a disappointing 2024 forecast Wednesday, denting shares as the company navigates a profound plunge in sales tied to the Covid-19 pandemic.

Investors Business Daily

Acadia Soars To A Four-Month High After Winning A Patent Battle For Its Biggest Drug

Acadia notched a win in a patent battle Wednesday pertaining to its Parkinson's drug and ACAD stock soared to a four-month high.

Investors Business Daily

IBD 50 Stocks To Watch: Biotech Leader Intra-Cellular Therapies Is Breaking Out Past A New Buy Point

Biotech leader Intra-Cellular Therapies is breaking out past a new buy point, making it one of the best stocks to buy and watch.

Get all your
news in one place.

100’s of premium titles.
One news app.

Top News

Supreme Court to Consider Restrictions on Abortion Drug Mifepristone

The Supreme Court is reconsidering the accessibility of popular abortion drug, Mifepristone, a high-stakes case with potential electoral repercussions.

The Hindu

Committee recommends curbs on freebies doled out by pharma companies

Committee recommends revising UCPMP to prohibit CMEs in foreign locations, disclose price of gifts to doctors, and make money received by doctors from pharma cos for research taxable.

Investors Business Daily

Vertex Breaks Out To Record High As It Takes On Opioids In Pain Treatment

Vertex solidified its potential for an alternative to opioids in pain treatment, an analyst said Wednesday. VRTX stock broke out.

Top News

FDA Seeks Power for Eyedrops Recalls Amid Foreign Inspections Woes

U.S. health officials grapple with inadequate inspection of overseas eyedrop factories, leading to recalls of potentially dangerous products.

The Independent UK

Safer eyedrops will require new FDA powers and resources, experts say

Repeated recalls of eyedrops are drawing new attention to the limited powers U.S. regulators have to oversee medical products made overseas

Investors Business Daily

Pfizer Crashes 7% After Issuing A Disappointing Outlook As Seagen Takeover Looms

Pfizer stock careened lower Wednesday after the company issued disappointing 2024 guidance ahead of its acquisition of Seagen.

Investors Business Daily

Here's What The FDA Approval Of Gene Editing For Sickle Cell Means For CRSP Stock And The Future Of Medicine

Biotech stocks could be at a major turning point after FDA approval of the first gene editing drug using Crispr technology. But gene editing therapies aren’t without risk, and questions remain about the safety and cost effectiveness of these experimental treatments.

1 … 28 29 30 31

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

National Crime Agency

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.